Buys
Open market- Shares
- +1,500
- Avg price
- $69.95
- Total value
- +$104,925
Quan Anh Vu - Chief Financial Officer at Monopar Therapeutics
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer symbol
- MNPR on Nasdaq
- Entity type
- Individual
- SEC filing history
- Open SEC filing history
Identity
1 identity field
Source evidence
1 source field
Past-year transaction volume for Quan Anh Vu in Monopar Therapeutics
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +1,500
- Share %
- 100%
- Total value
- +$104,925
Reported holdings for Quan Anh Vu in Monopar Therapeutics
Form 4 holding
Chief Financial Officer
Monopar Therapeutics
- Security class
- Common Stock
- Shares / value
- 1,500
- Estimated value
- $104,925
- Report date
- 26 Dec 2025
- Price
- $69.95
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
Monopar Therapeutics
- Security class
- Restricted Stock Units
- Shares / value
- 9,826
- Estimated value
- Report date
- 02 Dec 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
Monopar Therapeutics
- Security class
- Stock Options
- Shares / value
- 7,135
- Estimated value
- Report date
- 02 Dec 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Quan Anh Vu in Monopar Therapeutics
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.